{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T21:14:42Z","timestamp":1780521282454,"version":"3.54.1"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Preventive Medicine"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.ypmed.2022.107078","type":"journal-article","created":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T11:10:15Z","timestamp":1651835415000},"page":"107078","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Healthcare provider awareness of the recent FDA approval on first diagnostic tests for extragenital testing for chlamydia and gonorrhea"],"prefix":"10.1016","volume":"159","author":[{"given":"Guoyu","family":"Tao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas L.","family":"Gift","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ypmed.2022.107078_bb0005","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/QAI.0b013e3181c3ef29","article-title":"Rectal gonorrhea and chlamydia reinfection is associated with increased risk of HIV seroconversion","volume":"53","author":"Bernstein","year":"2010","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"Rr-02","key":"10.1016\/j.ypmed.2022.107078_bb0010","first-page":"1","article-title":"Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae--2014","volume":"63","author":"Centers for Disease Control and Prevention","year":"2014","journal-title":"MMWR Recomm. Rep."},{"issue":"10","key":"10.1016\/j.ypmed.2022.107078_bb0015","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1097\/00001888-200110000-00015","article-title":"Changes in health care providers\u2019 knowledge, attitudes, beliefs, and behaviors regarding domestic violence, following a multifaceted intervention","volume":"76","author":"Gadomski","year":"2001","journal-title":"Acad. Med."},{"issue":"1","key":"10.1016\/j.ypmed.2022.107078_bb0020","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1086\/430704","article-title":"Prevalence of rectal, urethral, and pharyngeal chlamydia and gonorrhea detected in 2 clinical settings among men who have sex with men: San Francisco, California, 2003","volume":"41","author":"Kent","year":"2005","journal-title":"Clin. Infect. Dis."},{"issue":"7","key":"10.1016\/j.ypmed.2022.107078_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss7007a1","article-title":"Demographic, behavioral, and clinical characteristics of persons seeking care at sexually transmitted disease clinics - 14 sites, STD surveillance network, United States, 2010-2018","volume":"70","author":"Llata","year":"2021","journal-title":"MMWR Surveill. Summ."},{"key":"10.1016\/j.ypmed.2022.107078_bb0030","author":"Novelli"},{"issue":"5","key":"10.1016\/j.ypmed.2022.107078_bb0035","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1197\/jamia.M2299","article-title":"The use of wireless e-mail to improve healthcare team communication","volume":"16","author":"O\u2019Connor","year":"2009","journal-title":"J. Am. Med. Inform. Assoc."},{"issue":"8","key":"10.1016\/j.ypmed.2022.107078_bb0040","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/cid\/cit437","article-title":"HIV incidence among men with and those without sexually transmitted rectal infections: estimates from matching against an HIV case registry","volume":"57","author":"Pathela","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ypmed.2022.107078_bb0045","author":"Sermo"},{"issue":"10","key":"10.1016\/j.ypmed.2022.107078_bb0050","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1093\/cid\/ciw594","article-title":"Rectal infection with Neisseria gonorrhoeae and Chlamydia trachomatis in men in the United States","volume":"63","author":"Tao","year":"2016","journal-title":"Clin. Infect. Dis."},{"issue":"4","key":"10.1016\/j.ypmed.2022.107078_bb0055","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1093\/cid\/cix857","article-title":"Infrequent testing of women for rectal Chlamydia and gonorrhea in the United States","volume":"66","author":"Tao","year":"2018","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ypmed.2022.107078_bb0060","series-title":"FDA Clears First Diagnostic Tests for Extragenital Testing for Chlamydia and Gonorrhea. U.S. Food and Drug Administration","author":"U.S. Food and Drug Administration","year":"2019"},{"issue":"Rr-03","key":"10.1016\/j.ypmed.2022.107078_bb0065","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines, 2015","volume":"64","author":"Workowski","year":"2015","journal-title":"MMWR Recomm. Rep."},{"issue":"4","key":"10.1016\/j.ypmed.2022.107078_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7004a1","article-title":"Sexually transmitted infections treatment guidelines, 2021","volume":"70","author":"Workowski","year":"2021","journal-title":"MMWR Recomm. Rep."}],"container-title":["Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743522001268?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743522001268?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T10:15:43Z","timestamp":1758795343000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091743522001268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":14,"alternative-id":["S0091743522001268"],"URL":"https:\/\/doi.org\/10.1016\/j.ypmed.2022.107078","relation":{},"ISSN":["0091-7435"],"issn-type":[{"value":"0091-7435","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Healthcare provider awareness of the recent FDA approval on first diagnostic tests for extragenital testing for chlamydia and gonorrhea","name":"articletitle","label":"Article Title"},{"value":"Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ypmed.2022.107078","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107078"}}